Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib) 2021-04-29 08:00
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration 2021-04-29 08:00
Essence Group Announces 'Peace of Mind' Strategy as Top Objective of All Future IoT Products and Services 2021-04-29 07:01
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" 2021-04-28 21:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology 2021-04-28 19:59
Turn Biotechnologies completes latest round of funding 2021-04-28 19:50
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute 2021-04-28 15:00
Genesis MedTech to Introduce Revolutionary Laparoscopic Technology to China and Singapore 2021-04-28 10:01
HMI Group and Siemens Healthineers enters into strategic partnership to advance healthcare delivery in Southeast Asia 2021-04-28 08:05
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care 2021-04-28 04:15
HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study 2021-04-27 21:33
Rare Brain Damaged Patient May Settle Controversy Over Fish Pain 2021-04-27 20:00
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK 2021-04-27 14:00
MSIG partners with Singapore Cancer Society to raise public awareness on cancer risks 2021-04-27 10:00
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone 2021-04-27 09:23
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer 2021-04-26 22:08
CStone Announces NMPA Acceptance of New Drug Application of Selective Inhibitor GAVRETO(R) (Pralsetinib) with Priority Review Designation for the Treatment of Advanced or Metastatic RET-Altered Thyroid Cancer Patients 2021-04-26 21:14
One-Stop CLIA Solution with Open Systems and Resources Makes Evolution to Emerging World Healthcare Systems 2021-04-26 15:17
1 291 292 293 294 295 532